Parkman Healthcare Partners LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $687 Million distributed in 89 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Gilead Sciences, Inc. with a value of $34.6M, Verona Pharma PLC with a value of $33.5M, Insulet Corp with a value of $32.8M, Boston Scientific Corp with a value of $30.1M, and Stryker Corp with a value of $28M.

Examining the 13F form we can see an decrease of $20.9M in the current position value, from $708M to 687M.

Parkman Healthcare Partners LLC is based out at Stamford, CT

Below you can find more details about Parkman Healthcare Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $687 Million
Healthcare: $683 Million
Industrials: $3.8 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 89
  • Current Value $687 Million
  • Prior Value $708 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 11 stocks
  • Additional Purchases 46 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 31 stocks
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.